Anand Parikh
Fortune : 27 M $ au 31/08/2026
Fortune : 27 M $ au 31/08/2026
Anand Parikh is the founder of Faeth Therapeutics LLC, founded in 2019, holding the titles of President, Chief Executive Officer & Director since 2026.
Mr. Parikh currently holds the position of Chairman, President & Chief Executive Officer at Faeth Therapeutics, Inc. since 2026.
Mr. Parikh completed undergraduate education at the University of Michigan and graduate education at New York University School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FAETH THERAPEUTICS, INC. 3,17 % | 21/07/2026 | 817 699 ( 3,17 % ) | 27 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| FAETH THERAPEUTICS, INC. | Directeur Général | 13/06/2026 |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Fondateur | 01/04/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops precision nutrition cancer treatment solutions which uses metabolism to starve cancer cells | Health Technology |
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops immunotherapies for cancers and infectious disease | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national